BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Asakura H, Suzuki K, Honma T. Recent advances in basic and clinical aspects of inflammatory bowel disease: Which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease? World J Gastroenterol 2007; 13(15): 2145-2149 [PMID: 17465491 DOI: 10.3748/wjg.v13.i15.2145]
URL: https://www.wjgnet.com/1007-9327/full/v13/i15/2145.htm
Number Citing Articles
1
Katia Abdelouhab, Hayet Rafa, Ryma Toumi, Samia Bouaziz, Oussama Medjeber, Chafia Touil-Boukoffa. Mucosal intestinal alteration in experimental colitis correlates with nitric oxide production by peritoneal macrophages: Effect of probiotics and prebioticsImmunopharmacology and Immunotoxicology 2012; 34(4): 590 doi: 10.3109/08923973.2011.641971
2
Dong-ha Kim, Ji-Su Kim, Jae-Hee Kwon, In-Sook Kwun, Moon-Chang Baek, Gi-Seok Kwon, Wiramon Rungratanawanich, Byoung-Joon Song, Do-Kyun Kim, Hyo-Jung Kwon, Young-Eun Cho. Ellagic Acid Prevented Dextran-Sodium-Sulfate-Induced Colitis, Liver, and Brain Injury through Gut Microbiome ChangesAntioxidants 2023; 12(10): 1886 doi: 10.3390/antiox12101886
3
Maciej Chichlowski, Laura P. Hale. Bacterial-mucosal interactions in inflammatory bowel disease—an alliance gone badAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2008; 295(6): G1139 doi: 10.1152/ajpgi.90516.2008
4
Romy Lauche, Holger Cramer, Petra Klose, Karin Kraft, Gustav J Dobos, Jost Langhorst. Herbal medicines for the treatment of inflammatory bowel diseaseCochrane Database of Systematic Reviews 2014;  doi: 10.1002/14651858.CD011223
5
Dimitrios Damaskos, George Kolios. Probiotics and prebiotics in inflammatory bowel disease: microflora ‘on the scope’British Journal of Clinical Pharmacology 2008; 65(4): 453 doi: 10.1111/j.1365-2125.2008.03096.x
6
Nada A. Helal, Heba A. Eassa, Ahmed M. Amer, Mohamed A. Eltokhy, Ivan Edafiogho, Mohamed I. Nounou. Nutraceuticals’ Novel Formulations: The Good, the Bad, the Unknown and Patents InvolvedRecent Patents on Drug Delivery & Formulation 2019; 13(2): 105 doi: 10.2174/1872211313666190503112040
7
Ulysses dos Santos Torres, Juliana Olsen Rodrigues, Melissa Silva Garcia Junqueira, Simone Uezato, João Gomes Netinho. The Montreal classification for Crohn's disease: clinical application to a Brazilian single-center cohort of 90 consecutive patientsArquivos de Gastroenterologia 2010; 47(3): 279 doi: 10.1590/S0004-28032010000300013
8
Mahdi Shadnoush, Rahebeh Shaker Hosseini, Ahad Khalilnezhad, Lida Navai, Hossein Goudarzi, Maryam Vaezjalali. Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical TrialThe Korean Journal of Gastroenterology 2015; 65(4): 215 doi: 10.4166/kjg.2015.65.4.215
9
Bernd B. Frericks, Frank Wacker, Christoph Loddenkemper, Steffi Valdeig, Birgit Hotz, Karl-Jürgen Wolf, Bernd Misselwitz, Anja Kühl, Jörg C. Hoffmann. Magnetic Resonance Imaging of Experimental Inflammatory Bowel DiseaseInvestigative Radiology 2009; 44(1): 23 doi: 10.1097/RLI.0b013e3181899025
10
Hayet Rafa, Houria Saoula, Mourad Belkhelfa, Oussama Medjeber, Imene Soufli, Ryma Toumi, Yvan de Launoit, Olivier Moralès, M'hamed Nakmouche, Nadira Delhem, Chafia Touil-Boukoffa. IL-23/IL-17A Axis Correlates with the Nitric Oxide Pathway in Inflammatory Bowel Disease: Immunomodulatory Effect of Retinoic AcidJournal of Interferon & Cytokine Research 2013; 33(7): 355 doi: 10.1089/jir.2012.0063
11
Omar I. Saadah, Turki AlAmeel, Ahmed Al Sarkhy, Mohammed Hasosah, Abdulrahman Al-Hussaini, Majid A. Almadi, Badr Al-Bawardy, Talal A. Altuwaijri, Mohammed AlEdreesi, Shakir A. Bakkari, Othman R. Alharbi, Nahla A. Azzam, Abdulelah Almutairdi, Khalidah A. Alenzi, Bedor A. Al-Omari, Hajer Y. Almudaiheem, Ahmed H. Al-Jedai, Mahmoud H. Mosli. Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescentsSaudi Journal of Gastroenterology 2024;  doi: 10.4103/sjg.sjg_171_24
12
Qi Zhang, Cuiping Zhang, Xiaoyu Li, Yanan Yu, Kun Liang, Xinzhi Shan, Kun Zhao, Qinghui Niu, Zibin Tian. WISP1 Is Increased in Intestinal Mucosa and Contributes to Inflammatory Cascades in Inflammatory Bowel DiseaseDisease Markers 2016; 2016: 1 doi: 10.1155/2016/3547096
13
Maricelma da Silva Soares de Souza, Sandra Maria Barbalho, Ricardo de Alvares Goulart, Antonely de Cássio Alves de Carvalho. The Current and Future Role of Drugs and Probiotics in the Management of Inflammatory Bowel DiseaseJournal of Biosciences and Medicines 2015; 3(08): 76 doi: 10.4236/jbm.2015.38008
14
Yosuke Nishitani, Koji Yamamoto, Masaru Yoshida, Takeshi Azuma, Kazuki Kanazawa, Takashi Hashimoto, Masashi Mizuno. Intestinal anti‐inflammatory activity of luteolin: Role of the aglycone in NF‐κB inactivation in macrophages co‐cultured with intestinal epithelial cellsBioFactors 2013; 39(5): 522 doi: 10.1002/biof.1091
15
S. He, T. Li, H. Chen, W. Ma, Q. Yao, H. Yang, H. Wang, F. Wang, C. Zhao, P. Yang. CD14+ cell-derived IL-29 modulates proinflammatory cytokine production in patients with allergic airway inflammationAllergy 2011; 66(2): 238 doi: 10.1111/j.1398-9995.2010.02455.x